High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders

Clinical trial NCT06313502 · RECRUITING

Trial details

NCT number: NCT06313502
Sponsor: University of Arkansas
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Plasma Cell Disorder

Start date: 2024-07-19
Primary completion: 2027-04-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.